Advertisement
Product › Details
CT327 (Creabilis)
Next higher product group | TrkA kinase inhibitor | |
Status | 2011-03-10 development p2 existent | |
Organisation | Creabilis S.A. | |
Group | Creabilis (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for kinase inhibitor
- [1] Mysthera Therapeutics AG. (8/21/23). "Press Release: Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies". Basel....
- [2] Nuvectis Pharma, Inc.. (9/14/21). "Press Release: Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland". Fort Lee, NJ....
- [3] Exscientia Ltd.. (7/21/21). "Press Release: Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture". Oxford & Shanghai....
- [4] Yukin Therapeutics SAS. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis....
- [5] Inflection Biosciences Ltd.. (4/16/18). "Press Release: Inflection Biosciences and Trinity College Dublin Announce Immuno-Oncology Research Collaboration". Dublin....
- [6] Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001"....
- [7] AstraZeneca plc. (11/15/17). "Press Release: Faslodex Receives US FDA Approval for the Treatment of Advanced Breast Cancer in Combination with Abemaciclib"....
- [8] Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne....
- [9] Genomic Vision S.A.. (5/23/17). "Press Release: Genomic Vision to Enter into Technological Collaboration with AstraZeneca in Oncology". Bagneux....
- [10] Redx Pharma plc. (5/17/17). "Press Release: Interim Results for the Six Months Ended 31 March 2017"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top